Iran

KEY RESULTS - HIV

 

258,000 counselling and testing encounters for HIV

Source: UNDP

Retention on ART 12 months after starting treatment (2016)

Source: UNAIDS

10,000 people currently on ART (2017)

Source: UNDP

Project Summary

UNDP has been the principal recipient of Global fund grants in Iran since 2005 for HIV, 2008 for TB and since 2011 for malaria. For HIV/AIDS, Iran is the only country in the region that has committed itself to reach the global target of 90-90-90 to help end the AIDS epidemic by 2020 and in line with these ambitious targets, the 4th National Strategic Plan and the Global Fund (GF) HIV grants have been developed and are being implemented. The key population of the HIV GF project are People Who Inject Drugs, HIV vulnerable women and Prisoners who are receiving HIV diagnostic test and other related prevention programmes, as well as treatment, care and support for People Living with HIV and their families through different settings of the project including Voluntary Counselling and Testing centres, Drop-In-Centres, Out-reach teams, Mobile Clinics and Positive Clubs. The project has also supported the national counterpart to improve Resilient and Sustainable System for Health. Iran was eligible to receive a continuation grant for the utilization period of April 2018 - March 2021 which is aligned with priorities in the 4th NSP with the goal of limiting prevalence rates among key populations (13% for injecting drug users and 5% for men and women engaged in risky sexual behaviour). There is also a target to reduce HIV related mortality by 20% over the same period. The aim of the malaria grant (no longer funded by the Global Fund) was elimination of P. Falciparum malaria by 2016 and all cases of malaria including P. Vivax by 2025. The TB programme (also no longer funded by the Global Fund) supported the priority gaps in the National Tuberculosis (TB) Control Programme, dramatically reducing the burden of TB in the poor and vulnerable populations in line with the SDGs and the Stop TB Partnership targets.  The programme included measures to enhance treatment practices, addressing issues related to TB/HIV combination and drug resistant, empowering TB affected people/communities, and enhancing TB control systems and infrastructure.

KEY RESULTS - MALARIA & TB

 

Case detection rate for TB in (2016). Above the global target (70%)

Source: World Health Organization

759,000 insecticide treated bed nets distributed

Source: UNDP

TB treatment success rate (2015)

Source: World Health Organization

Reported confirmed cases of Malaria

Source: World Health Organization

Maternal and infant mortality rates

Source: World Health Organization

PORTFOLIO OVERVIEW

 

Disease Component

HIV/ AIDS

Grant

IRN-H-UNDP

Phase

Period 2 (Apr 2018 - Mar 2021)

Amount

                        $10,687,693

Rating

 

Disease Component

Malaria

Grant

IRN-M-UNDP

Phase

Period 2 (Dec 2011 - Sep 2017) 

Amount

                        $20,538,984

Rating

 

 

Overall Grant Rating

 

 

  Exceeding expectations

 

  Meeting expectations

 

  Adequate

 

  Inadequate but potential demonstrated

 

  Unacceptable

 

  No rating available